We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$20.1B
AUM Growth
+$951M
Cap. Flow
-$224M
Cap. Flow %
-1.12%
Top 10 Hldgs %
32.44%
Holding
721
New
63
Increased
299
Reduced
261
Closed
36

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$55.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$46.1M
3
BABA icon
Alibaba
BABA
+$45M
4
NEE icon
NextEra Energy
NEE
+$40.9M
5
AMZN icon
Amazon
AMZN
+$38.3M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$50.3M
2
META icon
Meta Platforms (Facebook)
META
+$44.2M
3
PG icon
Procter & Gamble
PG
+$34.1M
4
ZTS icon
Zoetis
ZTS
+$33.6M
5
CAH icon
Cardinal Health
CAH
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 34.01%
2 Healthcare 26.73%
3 Financials 11.13%
4 Consumer Discretionary 7.93%
5 Communication Services 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYRE icon
226
Spyre Therapeutics
SYRE
$8.5B
$13.9M 0.07%
425,534
+21,172
+5% +$553K
T icon
227
AT&T
T
$164B
$13.9M 0.07%
559,013
+22,493
+4% +$569K
COHR icon
228
Coherent
COHR
$43.4B
$13.9M 0.07%
75,128
+21,689
+41% +$3.24M
SNOW icon
229
Snowflake
SNOW
$98.1B
$13.8M 0.07%
62,785
+7,092
+13% +$1.73M
MCO icon
230
Moody's
MCO
$83.7B
$13.7M 0.07%
26,892
+884
+3% +$431K
WMS icon
231
Advanced Drainage Systems
WMS
$10.6B
$13.6M 0.07%
93,956
-26,223
-22% -$3.8M
TMUS icon
232
T-Mobile US
TMUS
$195B
$13.4M 0.07%
65,933
-13,233
-17% -$2.81M
TMDX icon
233
Transmedics
TMDX
$2.7B
$13.3M 0.07%
+109,186
New +$13.7M
ROP icon
234
Roper Technologies
ROP
$40.4B
$13.1M 0.07%
29,426
+3,847
+15% +$1.78M
WDAY icon
235
Workday
WDAY
$41.5B
$13.1M 0.07%
60,922
+2,578
+4% +$586K
INTC icon
236
Intel
INTC
$413B
$13M 0.07%
353,420
+51,968
+17% +$1.96M
DFTX
237
Definium Therapeutics
DFTX
$5.6B
$13M 0.06%
+971,218
New +$12M
DNTH icon
238
Dianthus Therapeutics
DNTH
$5.69B
$12.8M 0.06%
311,150
+9,722
+3% +$377K
HON icon
239
Honeywell
HON
$76.4B
$12.7M 0.06%
65,041
+5,285
+9% +$1.03M
IEX icon
240
IDEX
IEX
$17B
$12.6M 0.06%
70,879
+6,633
+10% +$1.13M
EXEL icon
241
Exelixis
EXEL
$13.9B
$12.6M 0.06%
287,218
-408,886
-59% -$16.9M
LOW icon
242
Lowe's Companies
LOW
$121B
$12.5M 0.06%
51,841
+4,518
+10% +$1.08M
EWTX icon
243
Edgewise Therapeutics
EWTX
$4.28B
$12.4M 0.06%
501,214
+280,055
+127% +$5.62M
NET icon
244
Cloudflare
NET
$96B
$12.4M 0.06%
63,086
+675
+1% +$143K
ENSG icon
245
The Ensign Group
ENSG
$10.6B
$12.4M 0.06%
71,238
EYPT icon
246
EyePoint Inc
EYPT
$999M
$12.3M 0.06%
+674,395
New +$9.56M
IR icon
247
Ingersoll Rand
IR
$33.1B
$12.3M 0.06%
155,334
+27,732
+22% +$2.19M
WTRG icon
248
Essential Utilities
WTRG
$11.5B
$12.2M 0.06%
318,034
+8,629
+3% +$340K
SBUX icon
249
Starbucks
SBUX
$119B
$12.2M 0.06%
144,695
+9,933
+7% +$838K
ORKA
250
Oruka Therapeutics
ORKA
$5.31B
$12.1M 0.06%
400,509
+33,515
+9% +$934K

Similar funds

Candriam SCA's Q4 2025 Portfolio in Review

As of Q4 2025, Candriam SCA held 721 positions worth $20.1B, up 5% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q4 2025 filing shows 63 new, 299 increased, 261 reduced and 36 closed positions. Its largest new stake was Alibaba: 276,080 shares worth $40.5M. The largest sale was Equinix, an estimated $50.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2025 buy was Alibaba: 276,080 shares worth $40.5M.
  • Candriam SCA added most to AbbVie in Q4 2025, an estimated $55.1M increase.
  • Candriam SCA's biggest Q4 2025 reduction was Equinix, cutting an estimated $50.3M.
  • Candriam SCA fully exited Universal Display in Q4 2025, selling an estimated $27.1M.
  • Candriam SCA's ten largest holdings make up 32% of its $20.1B portfolio in Q4 2025.
  • Candriam SCA opened 63 new positions and closed 36 in Q4 2025.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $20.1B.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.